You just read:

Investigational Anti-PD-1 Immunotherapy BMS-936558 Showed Clinical Activity in Phase 1 Trial of Patients with Previously-Treated Non-Small-Cell Lung Cancer, Metastatic Melanoma and Renal Cell Cancer

News provided by

Bristol-Myers Squibb Company

02 Jun, 2012, 05:05 BST